The Medicines and Health Products Regulatory Agency (MHRA) announced the selection of five health technologies for its “AI Airlock” program.
AI Airlock aims to refine the regulatory process for AI-based medical devices and accelerate their safe introduction to the UK National Health Service (NHS) and patients in need.
Technologies chosen for this program include solutions targeting cancer and chronic respiratory diseases, as well as advances in radiological diagnostics. These AI systems promise to revolutionize the accuracy and efficiency of healthcare, potentially improving diagnostic tools and patient care.
The AI Airlock, as described by the MHRA, is a “sandbox” environment: an experimental framework designed to help manufacturers determine how best to collect real-world evidence to support regulatory approval of their devices.
Unlike traditional medical devices, AI models continue to evolve through learning, making it more complex to establish evidence of safety and effectiveness. The airlock enables this exploration in a monitored virtual environment, giving developers insight into the practical challenges of regulation while supporting the NHS’s wider adoption of transformative AI technologies.
Safely enabling healthcare innovation through AI
Laura Squire, leading figure in MedTech regulatory reform and chief executive of the MHRA, said: “New AI medical devices have the potential to increase the accuracy of healthcare decisions, gaining save time and improve efficiency, leading to better outcomes for the NHS and patients across all care settings.
“But we need to be sure that AI-based medical devices introduced into the NHS are safe, remain safe and perform as intended throughout their lifespan.”
Squire highlighted that the AI Airlock pilot enables collaboration “in partnership with technology specialists, developers and the NHS”, facilitating the exploration of best practice and accelerating safe patient access to innovative solutions.
Government officials praised the initiative for its forward-thinking framework.
Karin Smyth, Minister of State for Health, commented: “As part of our 10-year health plan, we are moving NHS care from analogue to digital, and this project will help bring the most promising technology to patients.
“AI has the power to revolutionize care by helping doctors diagnose diseases, automating time-consuming administrative tasks, and reducing hospitalizations by predicting future health problems. »
Science Minister Lord Vallance hailed the AI Airlock pilot as “a great example of government and business working together to enable them to turn ideas into products that improve lives”. He added: “This shows how good regulation can facilitate emerging technologies to the benefit of the UK and our economy. »
Selected technologies
Deploying AI-based medical devices requires meeting strict criteria to ensure innovation, patient benefits, and readiness for regulatory challenges. The five technologies selected for this inaugural pilot offer critical insights into the future of healthcare:
- Lenus stratification
Patients with chronic obstructive pulmonary disease (COPD) are among those who will benefit significantly from AI innovation. Lenus Stratify, developed by Lenus Health, analyzes patient data to predict the course of serious lung diseases, thereby reducing unplanned hospitalizations. The system enables healthcare providers to adopt earlier interventions, providing patients with a better quality of life while easing pressure on NHS resources.
- Philips Radiology Report Enhancer
Philips has integrated AI into existing radiology workflows to improve the efficiency and accuracy of critical radiology reports. This system uses AI to prepare the “Print” section of reports, summarizing critical diagnostic information for healthcare providers. By automating this process, Philips aims to minimize workload issues, human errors and communication issues, creating a smoother diagnostic experience.
- Federated AI Monitoring Service (FAMOS)
One of the recurring challenges in AI is the concept of “drift,” when changing real-world conditions harm system performance over time. Newton’s Tree developed FAMOS to monitor AI models in real time, report degradations, and enable rapid fixes. Hospitals, regulators and software developers can use this tool to ensure algorithms remain performant, adapting to changing circumstances while prioritizing patient safety.
- Personalized cancer management OncoFlow
Targeting the pressing healthcare challenge of reducing cancer treatment wait times, OncoFlow accelerates clinical workflows with its intelligent care pathway platform. Initially applied to breast cancer protocols, the system then aims to extend to other areas of oncology. With faster access to suitable therapies, patients are achieving increased survival rates despite increasing pressures from the NHS.
- Smart guideline
Developed to simplify complex clinical decision-making processes, SmartGuideline uses big language AI trained according to official NICE medical guidelines. This technology allows clinicians to ask routine questions and receive verified, accurate answers, eliminating the ambiguity associated with current AI language models. By integrating this tool, patients benefit from more precise treatments based on the most recent medical knowledge.
Wider implications
The influence of the AI airlock extends beyond its current applications. The MHRA expects the pilot results, expected in 2025, to inform future medical device regulations and create a clearer path forward for manufacturers developing AI-based technologies.
The evidence obtained will help shape post-Brexit UKCA marking processes, helping manufacturers comply with higher levels of transparency. By improving regulatory frameworks, the UK could position itself as a global hub for medical technology innovation while ensuring faster access to life-saving tools.
The urgency of these developments was highlighted earlier this year in Lord Darzi’s speech goodbye health and care. The report describes the “critical state” of the NHS, proposing AI interventions as a promising route to sustainability. The MHRA’s work on AI Airlock responds to one of the report’s key recommendations to enable regulatory solutions and “unlock the AI revolution” for healthcare advancements.
Although being selected in the AI Airlock pilot does not indicate regulatory approval, the chosen technologies represent a potential leap forward in applying AI to some of healthcare’s most pressing challenges . The coming years will test the potential of these solutions under regulatory control.
If successful, the MHRA initiative could redefine how pioneering technologies like AI are adopted in healthcare, balancing the need for speed, security and efficiency. With the NHS under immense pressure from growing demand, AI’s ability to increase clinician numbers, predict disease and streamline workflows could well be the game-changer the system needs all the time. emergency.
(Photo by National Cancer Institute)
See also: The role of AI in preventing skin cancer through behavior change
Want to learn more about AI and Big Data from industry leaders? Check AI and Big Data Exhibition taking place in Amsterdam, California and London. The full event is co-located with other premier events including Intelligent Automation Conference, BlockX, Digital Transformation WeekAnd Cybersecurity and Cloud Expo.
Check out more upcoming enterprise technology events and webinars from TechForge here.